Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Beta-2 Agonist vs Epinephrine for TTN
NCT05006235Phase 1Completed
- Start
- Feb 2014
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of salbutamol and epinephrine in transient tachypnea of the newborn (TTN) (3 arms). Primary endpoint: Duration of oxygen support & O2 concentration until Downes' score less than 4. Started Feb 2014; status: completed.
02
Drugs
salbutamolepinephrine
03
Conditions
transient tachypnea of the newborn (TTN)
Beyond the preview
Go deeper on NCT05006235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05006235.